The clinical trials market is evolving fast, but 2025 hasn’t been without its challenges. Rising costs, stricter global regulations, and recruitment delays are slowing progress for many pharma and biotech companies. While technology is helping, it’s clear the industry still faces some serious hurdles. What do you think is the biggest barrier clinical trials are facing right now?
Quem Está Navegando
0 membros estão online
Nenhum usuário registrado visualizando esta página.